Histologically benign PI-RADS 4 and 5 lesions contain cancer-associated epigenetic alterations. Seref C, Acar O, Kilic M, Vural M, et al. Prostate 2022;82:145-153.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Seref C, Acar O, Kilic M, Vural M, et al. Histologically benign PI-RADS 4 and 5 lesions contain cancer-associated epigenetic alterations. Prostate 2022;82:145-153.
PMID: 34672371